Article

PDXGEM: Patient-Derived Tumor Xenograft based Gene Expression Model for Predicting Clinical Response to Anticancer Therapy in Cancer Patients

2019-06-28

Abstract excerpt

<h4>Background</h4> Cancer is a highly heterogeneous disease and shows varying responses to anti-cancer drugs. Although several approaches have been attempted to predict the drug responses by analyzing molecular profiling data of tumors from preclinical cancer models or cancer patients, there is still a great need of developing highly accurate prediction models of response to the anti-cancer drugs for clinical ap...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 11779a24-79d5-5315-b33b-4f02cc8b8a7c
DOI: 10.1101/686667

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

PDXGEM: Patient-Derived Tumor Xenograft based Gene Expression Model for Predicting Clinical Response to Anticancer Therapy in Cancer PatientsDOI 10.1101/686667Read

A Pan-Cancer, Pan-Treatment (PCPT) Model For Predicting Drug Responses From Patient-Derived Xenografts With Application To Cancer Types With Sparse Training DataSemantic proximity Read

Machine learning models to predict <i>in vivo</i> drug response via optimal dimensionality reduction of tumour molecular profilesSemantic proximity Read

Dr.Paso: Drug response prediction and analysis system for oncology researchSemantic proximity Read

Predicting Tumor Response to Drugs based on Gene-Expression Biomarkers of Sensitivity Learned from Cancer Cell LinesSemantic proximity Read

Evaluating cancer cell line and patient-derived xenograft recapitulation of tumor and non-diseased tissue gene expression profiles <i>in silico</i>Semantic proximity Read

PDXNet Portal: Patient-Derived Xenograft model, data, workflow, and tool discoverySemantic proximity Read

Drug Sensitivity Prediction From Cell Line-Based Pharmacogenomics Data: Guidelines for Developing Machine Learning ModelsSemantic proximity Read

Predicting Tumor Response to Drugs Based on Gene-expression Biomarkers of Sensitivity Learned From Cancer Cell LinesSemantic proximity Read

A Transformative Technology Linking Patient’s mRNA Expression Profile to Anticancer Drug EfficacySemantic proximity Read

A Novel Patient-specific Protein Expression-based Algorithmic Model for Immune Checkpoint Inhibition Therapy Response Prediction in a Pan-cancer CohortSemantic proximity Read

Integrative Pharmacogenomics Analysis of Patient Derived XenograftsSemantic proximity Read

Prognostic impact of genomically matched therapy for solid cancers using real-world data from a provincial hospital in JapanSemantic proximity Read